2017 ASH Clinical Research Training Institute Participants, AML Matters Summit, and more

Fellows and Junior Faculty Selected for 2017 ASH Clinical Research Training Institute

Twenty hematology and hematology/oncology fellows and junior faculty will participate in the 2017 American Society of Hematology (ASH) Clinical Research Training Institute (CRTI), a year-long education and mentoring program designed to prepare participants for careers in patient-oriented clinical research.

CRTI began August 5 with a week-long workshop in La Jolla, California, supported in part by the National Cancer Institute and the National Heart, Lung, and Blood Institute. Participants attended lectures and small-group discussions focused on research questions, clinical trial design, regulatory issues, and funding. Two subsequent sessions, the first at the ASH annual meeting in December and the second at ASH headquarters in May, will provide opportunities for further interaction and mentoring.

For the full list of participants, read the press release at hematology.org/2017CRTI.

Opportunity to Comment on VTE Guidelines: Sign up for Updates!

ASH is developing 10 clinical practice guidelines to address the diagnosis and management of venous thromboembolism. As part of an evidence-based, transparent process that incorporates diverse stakeholder perspectives, draft recommendations for each guideline will be made available for public comment.

To sign up for email updates when guidelines are posted for comment, visit hematology.org/Guidelines-Public-Comment.

Lend a Helping Hand in Peru

ASH partners with Health Volunteers Overseas (HVO), a non-profit organization dedicated to improving global health through education, to bring invaluable consultation and training to hospitals in the developing world.

Central square of Arequipa, Peru

Volunteer your expertise to hematology staff and residents at the Catholic University of Santa Maria and its partner hospital, Carlos Alberto Seguin Escobedo Hospital, in Arequipa, Peru. Volunteers complete short-term assignments on site, during which they conduct hematology rounds, provide consultation in clinics and laboratories, and give lectures on requested topics.

Both sites in Peru manage a large cohort of patients with acute lymphocytic leukemia (ALL). Targeted training to address ALL − as well as lymphomas, other hematologic malignancies, and aplastic anemia − is needed, in addition to training in the interpretation of blood smears, bone marrow aspirates, flow cytometry, blood banking, and hematopathology.

Apply at hematology.org/HVO.

Annual Meeting Housing Fraud: Look out for Pirates

Pirate housing companies or travel agencies may solicit you over the phone or via email and misrepresent themselves as ASH’s official housing provider. SPARGO, Inc., is the only official housing provider for the 59th ASH Annual Meeting and Exposition.

Deceptive tactics used by pirate companies may include:

  • indicating that the hotel room block is sold out and that attendees must book with a company immediately to secure a room
  • distributing forms or promotional materials that appear to be issued by ASH
  • failing to deliver on promises − when customers arrive, reservations may be non-existent or hotels may be inconveniently located
  • representing themselves as ASH affiliates by illegally using ASH’s name or logo

If you are contacted by a pirate company, please notify the ASH Housing Center immediately at [email protected].

Attend AML Matters Summit in October

The last two opportunities to attend the AML Matters educational program are October 20 in Durham, North Carolina, and October 27 in Philadelphia, Pennsylvania. AML Matters is designed to provide health-care professionals guidance on the optimal diagnosis and classification of acute myeloid leukemia, risk stratification, individualized treatment selection, assessment of treatment responses, monitoring for and mitigation of adverse events, and patient education regarding prognosis and treatment choices. This program is sponsored by ASH, the American Society for Clinical Pathology, the National Marrow Donor Program, the Oncology Nursing Society, and The France Foundation.

Learn more at hematology.org/summit.

There’s Still Time for Late-Breaking Abstracts

Because the results of some top-quality research may not be available by the general abstract submission deadline, authors may submit late-breaking abstracts October 20-30, 2017. Authors must explain why their abstract was not ready by the regular deadline (August 2). This information will be available to reviewers.

Late-breaking abstracts will undergo regular peer-review evaluation, and up to six abstracts will be accepted for presentation at the ASH annual meeting and published online.

SHARE